GBM76 GBM Model

GBM76, a Patient-Derived Xenograft (PDX) model, empowers brain cancer research. Explore its unique features to gain valuable insights and develop innovative therapies. PDX models like GBM76 are indispensable for preclinical drug discovery, offering a controlled environment for drug testing. GBM76 faithfully replicates the patient’s tumor, enabling researchers to assess treatment efficacy and safety comprehensively. By leveraging GBM76, you contribute to the advancement of brain cancer treatments and the improvement of patient care.

Model Details

Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM76
Mouse Strain: Nu/Nu
WES: Yes
RNAseq: Yes
Methylation: Yes
EGFR Exon Varient: EGFRvIII
Patient Treatment History: Yes

GBM76 Survival

Survival of orthotopic intracranial implanted  GBM76 in Nu/Nu mice  (n=5)

Request Additional GBM Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content